In the news release, Achieve the Beautiful Bikini Body for Summer: Syneron Teams with TV's THE Doctors To Offer a Free VelaShape Cellulite Treatment, issued 07-Apr-2010 by Syneron Medical Ltd. over PR Newswire, we are advised by the company that the second paragraph, first sentence, should read "During the April 23 episode of THE Doctors, Dr. Glynis Ablon of the Ablon Skin Institute in Manhattan Beach, Calif. and Assistant Clinical Professor at UCLA will demonstrate how VelaShape treatments can help consumers achieve the toned, smooth physique they desire before summer." rather than "During the April 9 episode" as originally issued inadvertently. The complete, corrected release follows:
Achieve the Beautiful Bikini Body for Summer: Syneron Teams with TV's THE Doctors To Offer a Free VelaShape Cellulite Treatment
IRVINE, Calif., April 7 /PRNewswire-FirstCall/ -- Syneron(TM) Medical Ltd. (Nasdaq: ELOS), http://www.syneron.com, an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today launched its "VelaShape into Summer" promotion. Now through June 30, 2010 bikini-hopefuls nationwide can download a voucher at www.velashape.com to be used towards one free treatment of the leading non-invasive, cellulite and body contouring treatment.
(Photo: http://www.newscom.com/cgi-bin/prnh/20100407/DE82695 )
During the April 23 episode of THE Doctors, Dr. Glynis Ablon of the Ablon Skin Institute in Manhattan Beach, Calif. and Assistant Clinical Professor at UCLA will demonstrate how VelaShape treatments can help consumers achieve the toned, smooth physique they desire before summer. As the first FDA approved non-invasive treatment, physicians have been using VelaShape to help women and men around the world smooth cellulite, shed inches and sculpt curves.
"As many of my patients are gearing up for summer vacations, the idea of getting into a swimsuit can be daunting," says Dr. Glynis Ablon. "I'm consistently impressed with the results I'm able to offer my patients with VelaShape. I recommend this treatment for patients who are looking to smooth cellulite, achieve more visible tone, or just to tighten loose skin or small pockets of fat without liposuction."
"Getting VelaShape was a great way to help me get ready for bathing suit season and smooth the lumps and bumps," said Cathy Davis, patient of Dr. Ablon featured on THE Doctors. "The treatments were comfortable, easy and painless and gave me the confidence I need to feel great in anything I put on this summer!"
In multiple controlled clinical studies, VelaShape patients saw an average loss of one inch on the thigh, two inches around the buttocks, and nearly three inches in the abdomen after five treatments. VelaShape is an ideal treatment for patients seeking to tone up and tighten a variety of troublesome areas on the body. Patients should receive four to six treatments, spaced one week apart to achieve optimum results. Most patients experience no side effects, though a few may exhibit some short-term local reddening on the area treated.
To find a VelaShape treatment provider near you, download a voucher for one free treatment, or for more information, please visit http://www.velashape.com.
Catch new episodes of THE Doctors every weekday. For local listings, please visit http://www.thedoctorstv.com/main/local_listings.
About Syneron Medical Ltd.
Syneron Medical Ltd. (Nasdaq: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets, services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide. Additional information can be found at www.syneron.com and www.candelalaser.com.
SOURCE Syneron Medical Ltd.